Mechanisms of the in vitro fungicidal effects of human neutrophils against Penicillium marneffei induced by granulocyte-macrophage colony- stimulating factor (GM-CSF)

Clinical and Experimental Immunology

Volumn 119, Issue 3, 2000, Pages 472-478

  Kudeken, N ^a   Kawakami, Kazuyoshi ^a   Saito, A ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Direct contact; GM CSF; Granular lysates; Neutrophil; Penicillium marneffei

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SUPEROXIDE DISMUTASE;

ARTICLE; CANDIDA ALBICANS; CELL STIMULATION; CONTROLLED STUDY; EXOCYTOSIS; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; GROWTH INHIBITION; HEAT TREATMENT; HUMAN; HUMAN CELL; NEUTROPHIL; PENICILLIUM MARNEFFEI; PRIORITY JOURNAL;

EID: 0034016856     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01158.x     Document Type: Article

References (36)

1. 1 Diamond RD, Krzesicki R, Jao W. Damage to pseudohyphal forms of Candida albicans by neutrophil in the absence of serum in vitro. J Clin Invest 1978; 61:349-59.
2. 2 Rex JH, Bennett JE, Gallin JI, Malech HL, Melnick DA. Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. J Infect Dis 1990; 162:523-8.
3. 3 Diamond RD, Root RK, Bennett JE. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J Infect Dis 1972; 125:367-76.
4. 4 Kurita N, Brummer E, Yoshida S, Nishimura K, Miyaji M. Antifungal activity of murine polymorphonuclear neutrophils against Histoplasma capsulatum. J Med Vet Mycol 1991; 29:133-43.
5. 5 Drutz DJ, Frey CL. Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeasts. J Lab Clin Med 1985; 105:737-50.
6. 6 Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirithanthana T. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 1994; 344:110-3.
7. 7 Dixon DM, McNeil MM, Cohen ML, Gellin BG, La Montagne JR. Fungal infections: a growing threat. Public Health Report 1996; 111:226-35.
8. 8 Dupont B, Denning DW, Marriott D, Sugar A, Viviani MA, Sirisanthana T. Mycoses in AIDS patients. J Med Vet Mycol 1994; 32 (Suppl. 1):65-77.
9. 9 Kaplan JE, Hu DJ, Holmes KK, Jaffe HW, Masur H, De Cock KM. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world. Am J Trop Med Hyg 1996; 55:1-11.
10. 10 Hilmarsdottir I, Meynard JL, Rogeaux O et al. Disseminated Penicillium marneffei infection associated with human immunodeficiency virus: a report of two cases and review of 35 published cases. J Acquir Immune Defic Syndr 1993; 6:466-71.
11. 11 Kudeken N, Kawakami K, Kusano N, Saito A. Contribution of cell-mediated immunity in host resistance against infection caused by Penicillium marneffei. J Med Vet Mycol 1996; 34:371-8.
12. 12 Gasson JC, Weisbart RH, Kaufman SE, Clark SC, Hewick RM, Wong GG. Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. Science 1984; 226:1339-42.
13. 13 Burgess AW, Begley CG, Johnson GR et al. Purification and properties of bacterially synthesized human granulocyte-macrophage colony stimulating factor. Blood 1987; 69:43-51.
14. 14 Lopez AF, Williamson DJ, Gamble JR et al. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 1986; 78:1220-8.
15. 15 Arnaout MA, Wang EA, Clark SC, Sieff CA. Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins of mature granulocytes. J Clin Invest 1986; 78:597-601.
16. 16 Kowanko IC. Granulocyte-macrophage colony-stimulating factor augments neutrophil killing of Torulopsis glabrata and stimulates neutrophil respiratory burst and degranulation. Clin Exp Immunol 1991; 83:225-30.
17. 17 Kudeken N, Kawakami K, Saito A. CD4 + T cell-mediated fatal hyperinflammatory reactions in mice infected with Penicillium marneffei. Clin Exp Immunol 1997; 107:468-73.
18. 18 Sekhon AS, Garg AK, Padhye AA, Hamir Z. In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole. Eur J Epidemiol 1993; 9:553-8.
19. 19 Ferrante A, Thong YH. Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method. J Immunol Methods 1980; 36:109-17.
20. 20 Panyutich A, Shi J, Boutz PL, Zhao C, Ganz T. Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infect Immun 1997; 65:978-85.
21. 21 Kudeken N, Kawakami K, Saito A. Cytokine-induced fungicidal activity of human polymorphonuclear leukocytes against Penicillium marneffei. FEMS Immunol Med Microbiol 1999; 26:115-124.
22. 22 Valerius NH. In vitro effect of colchicine on neutrophil granulocyte locomotion. Assessment of the effect of colchicine on chemotaxis, chemokinesis and spontaneous motility, using a modified reversible Boyden chamber. Acta Pathol Microbiol Scand 1978; 86:149-54.
23. 23 Garrison RG, Boyd KS. Dimorphism of Penicillium marneffei as observed by electron microscopy. Can J Microbiol 1973; 19:1305-9.
24. 24 Deng ZL, Connor DH. Progressive disseminated penicilliosis caused by Penicillium marneffei. Am J Clin Pathol 1985; 84:323-7.
25. 25 Kudeken K, Kawakami K, Saito A. Different susceptibilities of yeasts and conidia of Penicillium marneffei to nitric oxide-mediated fungicidal activity of murine macrophages. Clin Exp Immunol 1998; 112:287-93.
26. 26 Kudeken K, Kawakami K, Saito A. Role of superoxide anion in the fungicidal activity of murine peritoneal exudate macrophages against Penicillium marneffei. Microbiol Immunol 1999; 43:323-30.
27. 27 Chan YF, Chow TC. Ultrastructural observations on Penicillium marneffei in natural human infection. Ultrastruct Pathol 1990; 14:439-52.
28. 28 Cogliati M, Roverselli A, Boelaert JR, Taramelli D, Lombardi L, Viviani MA. Development of an in vitro macrophage system to assess Penicillium marneffei growth and susceptibility to nitric oxide. Infect Immun 1997; 65:279-84.
29. 29 Lopez AF, Williamson DJ, Gamble JR et al. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 1986; 78:1220-8.
30. 30 Klebanoff SJ. Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. Semin Hematol 1975; 12:117-42.
31. 31 Diamond RD, Krzesicki R. Mechanisms of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum, and of subsequent damage to pseudohyphae by microbicidal processes of neutrophils in vitro. J Clin Invest 1978; 61:360-9.
32. 32 Diamond RD. Fungal surfaces: effects of interactions with phagocytic cells. Rev Infect Dis 1988; 10 (Suppl. 2):S428-S431.
33. 33 Zurier RB, Weissmann G, Hoffstein S, Kammerman S, Tai HH. Mechanisms of lysosomal enzyme release from human leukocytes: II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J Clin Invest 1974; 53:297.
34. 34 Levy O. Antibiotic proteins of polymorphonuclear leukocytes. Eur J Haematol 1996; 56:263-77.
35. 35 Diamond RD, Krzesicki R, Epstein B, Jao W. Damage to hyphal forms of fungi by human leukocytes in vitro. Am J Pathol 1978; 91:313-28.
36. 36 Ganz T, Selsted ME, Szklarek D, Harwig SSL, Daher K, Bainton DF, Lehrer RI. Defensins;. natural peptide antibiotics of human neutrophils. J Clin Invest 1985; 76:1427-35.